STOCK TITAN

Omnicell Com reported $1.2B in revenue and $2.1M in net income for fiscal 2025. See the full OMCL financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations

TraceLink’s DSCSA capabilities are being embedded into Omnicell’s central pharmacy workflows to streamline hospital compliance, verification, and recall response.

(Neutral)
(Positive)
Tags

Omnicell (OMCL) and TraceLink announced an integration that embeds TraceLink's Drug Supply Chain Security Act (DSCSA) compliance solution into Omnicell central pharmacy inventory management workflows.

The integration brings serialized product verification, traceability, exception resolution, and compliance reporting directly into medication receiving, aiming to reduce manual effort and eliminate separate compliance tools. Hospitals and health systems are expected to verify serialized medicines within existing workflows, improve audit‑ready reporting, and respond more quickly to recalls using accurate serialized medicine data exchanged over TraceLink's Integrate-Once Agentic Business Network, which connects more than 315,000 authenticated entities and supports hundreds of billions of supply chain transactions.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market Context

OMCL’s pre-headline close was $34.71 on September 2. This frames the integration as an operational a...
Analysis

OMCL’s pre-headline close was $34.71 on September 2. This frames the integration as an operational announcement rather than a disclosed financial result; the -1.85% reaction on August 31 adds historical context. Adoption and execution remain risks to watch.

Key Figures

Authenticated entities: 315,000 authenticated entities Annual transactions: Hundreds of billions of annual supply chain transactions Company history: Since 1992
3 metrics
Authenticated entities 315,000 authenticated entities Integrate-Once Agentic Business Network
Annual transactions Hundreds of billions of annual supply chain transactions Integrate-Once Agentic Business Network
Company history Since 1992 Omnicell company description

Historical Context

5 past events · Latest: Aug 31 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Aug 31 Healthcare conference notice Neutral -1.9% Omnicell scheduled a Wells Fargo Healthcare Conference presentation for September 9.
Jul 30 Product launch Positive -4.7% EnlivenHealth launched VaxReach, a pharmacy vaccine outreach program.
Jul 30 Second-quarter earnings Positive -10.4% Omnicell reported second-quarter revenue growth and raised several 2026 outlook measures.
Jul 13 Earnings date notice Neutral -1.6% Omnicell scheduled its second-quarter 2026 results release for July 30.
Jul 01 Leadership appointment Positive +1.0% Nnamdi Njoku became Omnicell President while continuing as COO.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent positive or neutral news events generally coincided with negative 24-hour reactions, with the July 1 leadership announcement as the exception.

Key Terms

dscsa
1 terms
dscsa regulatory
"Drug Supply Chain Security Act (DSCSA) compliance solution"
The DSCSA is a U.S. federal law that creates a system to track and verify prescription drugs as they move through the supply chain, from manufacturers to dispensers. It requires unique identification, electronic transaction records, and processes for verifying and tracing products to prevent counterfeit, theft, or diversion; think of it as a digital chain-of-custody for medicines. Investors care because compliance and traceability affect costs, regulatory risk, and the reliability of drug supply for manufacturers, distributors, and pharmacies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Integration brings serialized product verification and traceability directly into medication receiving workflows, intended to enable more efficient pharmacy operations without separate compliance processes.

BOSTON, Sept. 3, 2026 /PRNewswire/ -- TraceLink, the world's largest Agentic Business Network for the life sciences and healthcare supply chain, today announced an integration between its Drug Supply Chain Security Act (DSCSA) compliance solution and the pharmacy inventory management systems of Omnicell, Inc. (Nasdaq: OMCL), a leading healthcare technology provider focused on empowering autonomous medication management. This integration is expected to enable hospitals and health systems to manage product verification, traceability, and compliance as part of everyday medication receiving workflows.

TraceLink logo

Medication shipments received by a hospital or health system pharmacy must be verified, documented, incorporated into inventory, and made available for patient care. When verification or data discrepancies occur, pharmacy teams must also resolve compliance exceptions while maintaining accurate records for regulatory reporting. While the DSCSA established new standards for product verification and traceability, many pharmacy teams still rely on separate compliance tools and manual processes alongside their operational workflows. Managing compliance outside the pharmacy system can add complexity, consume valuable staff time, and create unnecessary interruptions during medication receiving.

Through this integration, hospitals can access TraceLink's DSCSA capabilities directly within Omnicell central pharmacy inventory management workflows. Pharmacy teams can verify serialized products, access traceability information, resolve product verification exceptions, complete compliance reporting, and document receiving activities as medications are received, intended to help reduce manual effort, eliminate disconnected processes, and streamline pharmacy operations without changing established workflows.

TraceLink's DSCSA solution is built on the Integrate-Once™ Agentic Business Network, which links more than 315,000 authenticated entities across life sciences and healthcare and supports hundreds of billions of annual supply chain transactions. By extending this trusted digital infrastructure into hospital pharmacy operations, healthcare organizations are expected to gain immediate access to accurate serialized medicine information exchanged across the broader life sciences supply chain, improve confidence in product authenticity while enabling faster product verification, more efficient compliance exception resolution, and targeted response when recalled products enter the pharmacy.

"Hospital pharmacies shouldn't have to choose between maintaining regulatory compliance and operating efficiently," said Shabbir Dahod, President and CEO of TraceLink. "By integrating TraceLink's trusted DSCSA network with Omnicell's central pharmacy inventory management workflows, we're able to embed verification and traceability directly into medication receiving so pharmacy teams spend less time managing compliance processes and more time ensuring medicines are available for patient care."

Together, TraceLink and Omnicell are working to help hospitals and health systems:

  • Verify serialized medicines within existing medication receiving workflows.
  • Reduce manual effort associated with DSCSA compliance and audit-ready reporting.
  • Resolve product verification and compliance exceptions more efficiently.
  • Improve traceability to support faster identification of affected recalled products.
  • Increase operational efficiency while supporting medication safety and availability.

Sundar Tamma, Vice President of Product Management for Hospital Solutions at Omnicell, said, "Hospital pharmacies continue to face increasing operational demands with limited resources. The integration of TraceLink's solution expands the range of DSCSA integrations available to Omnicell Central Pharmacy Manager customers, providing additional options to support compliance while preserving the efficient workflows pharmacists depend on every day."

As hospital pharmacies continue to modernize medication management, the same trusted serialized medicine information should be able to support broader operational capabilities—including faster compliance exception resolution, targeted recall management, and future intelligent pharmacy workflows—without requiring separate data sources or disconnected compliance systems. This integration represents another step toward embedding trusted supply chain information directly into the systems healthcare providers use every day to deliver safe, efficient patient care.

Learn more about TraceLink's DSCSA compliance solutions for hospitals and health systems.

About TraceLink
TraceLink powers the transformation to an Agentic Supply Chain Operating Model, enabling organizations to perform and improve supply chain work across their business and trading partner networks. The Agentic Supply Chain Operating System, built on the OPUS Platform, brings together Agentic Business Processes, Agentic Control Towers, governed OPUS Agents, with the Integrate-Once™ Agentic Business Network to link systems, end-to-end business transactions, and collaborative peer-to-peer processes to create trusted, real-time operational context. In this agentic environment, humans and agents work together with greater speed, reasoning, control, and accountability to improve organizational productivity, service, inventory, working capital, cost, compliance, quality, resilience, and revenue performance.

Learn more at www.tracelink.com.

About Omnicell
Since 1992, Omnicell has been committed to delivering innovative, outcomes-centric pharmacy and nursing solutions for all settings of care. As an intelligent medication management technology company, Omnicell empowers autonomous medication management by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities worldwide.

Learn more at https://www.omnicell.com/ 

OMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tracelink-and-omnicell-integrate-dscsa-compliance-solution-into-hospital-pharmacy-operations-302869042.html

SOURCE TraceLink, Inc.

FAQ

What benefits does the DSCSA integration offer to Omnicell (OMCL) hospital and health system customers?

The integration is intended to reduce manual effort, eliminate disconnected compliance processes, and improve operational efficiency. Hospitals may verify serialized medicines in-line, support audit‑ready reporting, resolve compliance exceptions more efficiently, and identify recalled products faster.